L
Lincoln Pharmaceuticals
LINCOLN Share Price
Healthcare616.60
as on 09 Mar 2026 at 15:43
Market Cap
₹1,235 Cr
PE Ratio
14.10
ROCE
16.08%
LINCOLN Fundamentals
Company Valuation
Market Cap (₹ Cr.)
1,235
PE Ratio
14.10
PB Ratio
1.73
Dividend Yield
0.29%
ROE
12.26%
ROCE
16.08%
Book Value (₹)
357.35
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 49.78% | 49.78% | 49.78% | 49.78% | 49.78% |
| Domestic Institutional Investors (DII) | 0.00% | 0.01% | 0.01% | 0.01% | 0.01% |
| Foreign Institutional Investors (FII) | 5.16% | 5.00% | 5.14% | 4.72% | 4.70% |
| Public Investors | 36.71% | 36.64% | 36.27% | 36.26% | 36.29% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
LINCOLN Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
531633
NSE Scrip Name
LINCOLN
ISIN
INE405C01035



